p38-a MAPK-IN-4 (Compound 69) is a selective p38a MAPK inhibitor with anIC5o of 1.5 uM. p38-a MAPK-IN-4 rapidly and strongly prevents the development of mechanical allodynia (MA) in vivo[1].

Product information

CAS Number: 2396754-57-5

Molecular Weight: 341.20

Formula: C17H13BrN2O

Smiles: O=C1NC=C(C=C1C1=CC=CC=C1Br)NC1C=CC=CC=1

InChiKey: OAKQUGAXVQPKJW-UHFFFAOYSA-N

InChi: InChI=1S/C17H13BrN2O/c18-16-9-5-4-8-14(16)15-10-13(11-19-17(15)21)20-12-6-2-1-3-7-12/h1-11,20H,(H,19,21)

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: To be determined

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.